On October 1, 2027, essentially every IPPS hospital in the United States that isn't already in TEAM will be mandatorily at 90-day episode risk for hip, knee, and ankle replacement.
CJR-X is the most aggressive expansion of mandatory episode-based payment in the history of the Innovation Center.
The original CJR model ran in 67 MSAs from 2016 to 2024 and generated $112.7M in net Medicare savings across 98,000 episodes at 323 hospitals while maintaining quality. CMS read that result and concluded, reasonably, that the intervention works. CJR-X takes it nationwide, bolts on outpatient LEJR and total ankle, keeps the 90-day window, adds a quality-first composite score gate, a 5% stop-loss for dual-eligible-heavy hospitals, 29 risk adjusters, and a waiver of the SNF 3-day stay rule. Projected 5-year savings: $725M.
Read it alongside TEAM and the doubling down on accountable care seems more steadfast. TEAM holds 729 hospitals accountable for 30-day surgical episodes starting this year. CJR-X picks up almost everyone else for 90-day joint replacement episodes starting late 2027. Together they represent something CMS has never done before: near-universal mandatory episode risk for orthopedic surgery.
This lands at a difficult moment. Primary TJA reimbursement is down 56% since 2000. The 2026 Physician Fee Schedule added another 2.5% efficiency cut on surgical procedures. Demand is projected to nearly triple by 2040. You cannot keep compressing procedural payment on the most cost-effective intervention in all of medicine and simultaneously expand episode accountability without building new infrastructure to capture value beyond the cut.
Benjamin Schwartz, MD, MBA and I are going to dig in on the model Thursday:
→ What does CJR-X change for hospitals already thinking about TEAM — and what does it mean for the ones that assumed mandatory bundles wouldn't reach them?
→ Where does the 90-day window create real operational opportunity (post-acute navigation, PT partnerships, readmission prevention) versus where it creates brittle risk for hospitals without the infrastructure to manage it?
→ How do we think about gainsharing, physician alignment, and the role of ASCs and HOPDs as outpatient LEJR volume keeps migrating?
Going live Thursday on the Techy Surgeon Substack with Benjamin Schwartz, MD, MBA to dive in on the model and discuss the shifting incentives of musculoskeletal care. If you're an orthopedic surgeon, hospital CFO, a service-line leader, or anyone trying to make sense of where MSK value-based care is actually heading — come join us.
A reminder, public comment on CJR-X closes June 9. (Also if you haven't checked out the new Chat GPT Image module it's pretty incredible and made the anime portrait of us below).
